no scripts enabled
Medikabazaar
Cart
Claribid 500mg Tablet 10's
Claribid 500mg Tablet 10's: Image 1
Claribid 500mg Tablet 10's: Image 2
Claribid 500mg Tablet 10's: Image 3
Claribid 500mg Tablet 10's: Image 4
Claribid 500mg Tablet 10's: Image 5

Your Advantages

Brand Abbott India

Claribid 500mg Tablet 10's contains Clarithromycin 500 mg, a semi-synthetic macrolide antibiotic used to manage a wide range of bacterial infections. This medication is effective against various upper and lower respiratory tract infections, including pharyngitis, sinusitis, bronchitis, and pneumonia.


As an anti-infective agent, Claribid 500mg Tablet 10's is also indicated for middle ear infections (acute otitis media), skin and soft tissue infections such as impetigo, folliculitis, cellulitis, and abscesses. It is further utilized in the treatment of tooth and mouth infections, duodenal ulceration associated with Helicobacter pylori infection, and disseminated or localized mycobacterial infections in adults, children, and adolescents above 12 years of age.


This oral tablet formulation is designed for convenient administration, with each pack containing 10 tablets. Proper storage is essential to maintain efficacy, requiring the tablets to be kept at a temperature not exceeding 30°C and protected from moisture and direct light.


Key Features : 

Active ingredient: Clarithromycin 500 mg, a macrolide antibiotic
Therapeutic Class: Anti-Infectives (Systemic)
Licensed Indications: Treatment of upper and lower respiratory tract infections, middle ear infections, skin and soft tissue infections, tooth and mouth infections, duodenal ulceration with H. pylori, and mycobacterial infections
Storage Conditions: Store at a temperature not exceeding 30°C, protected from moisture and direct light
Regulatory Approval: Classified as a Schedule H prescription drug, requiring a prescription from a Registered Medical Practitioner
Active Ingredient(s)Clarithromycin 500 mg
Therapeutic ClassMacrolide Antibiotics
Dosage FormTablet
Storage ConditionsStore at a temperature not exceeding 30°C, protect from moisture
Regulatory Approval (CDSCO Schedule)SCHEDULE H PRESCRIPTION DRUG-CAUTION
Release TypeImmediate-release
Licensed IndicationsUpper respiratory tract infections, lower tract respiratory infections, middle ear infections, skin and soft tissue infections, tooth and mouth infections, duodenal ulceration and helicobacter pylori infection, mycobacterial infections
twitterlinkedinfacebookinstagramyoutube
@Copyright Boston Ivy Healthcare Solutions Private Limited